CRISPR and gene editing for kidney diseases: where are we? [PDF]
D'Ambrosio V +6 more
europepmc +1 more source
Enhancing the specificity of gene editing outcomes by using Cas9 variants in porcine embryos. [PDF]
Kim J +8 more
europepmc +1 more source
Advances and challenges of CRISPR/Cas gene editing for corneal diseases. [PDF]
Han Y, Chen R, Shentu X.
europepmc +1 more source
Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editing. [PDF]
Liu L +19 more
europepmc +1 more source
Stage- and tissue-specific gene editing using 4-OHT-inducible Cas9 in whole organism. [PDF]
Li Y +9 more
europepmc +1 more source
CRISPR-Cas9 Gene Editing in <i>Aspergillus</i>: From Pathogenesis to Metabolic Engineering. [PDF]
Hu D, Zhao R, Lin Y, Jiang C.
europepmc +1 more source
Gene editing using gamma modified PNA: HBB gene as a model. [PDF]
Eltaweel N +6 more
europepmc +1 more source
CRISPR gene editing of AtRING1 unravels a critical role of RAWUL domain in PRC1 repression of transcription. [PDF]
Wang Q, Chen D, Berr A, Shen WH.
europepmc +1 more source
Multiplex Gene Editing and Effect Analysis of Yield, Fragrance, and Blast Resistance Genes in Rice. [PDF]
Guan S +6 more
europepmc +1 more source
Engineered Cas9 exosome vesicles as a novel gene editing tool for targeted ASPN editing in osteoarthritis. [PDF]
Lou C +14 more
europepmc +1 more source

